Drug Development

Area of Science:

• Neuroscience
• Medical Research

Background:

• Non-invasive 40Hz gamma frequency sensory stimulation is a potential therapeutic for Alzheimer's disease (AD).
• The specific human brain regions generating gamma responses to Gamma Entrainment Using Sensory (GENUS) stimulation remain uncharacterized.

Purpose of the Study:

• To identify the brain regions that generate gamma frequency oscillations in response to GENUS stimulation.
• To investigate the neural substrates underlying the therapeutic potential of 40Hz sensory stimulation for cognitive disorders.

Main Methods:

• An observational trial involving 16 cognitively typical subjects using magnetoencephalography (MEG).
• Subjects received 40Hz light and sound stimulation via the GENUS device during MEG recording.
• MEG data was mapped onto individual MRI scans for source localization of 40Hz oscillations.

Main Results:

• GENUS stimulation induced 40Hz oscillations in sensory cortices and brain regions vital for memory, spatial orientation, and sensory integration.
• Maximal 40Hz oscillation induction occurred with synchronized light and sound stimulation.
• Anticorrelated light and sound stimulation significantly reduced 40Hz oscillations in auditory and visual cortices.

Conclusions:

• This study provides the first evidence of target engagement and identifies sources of gamma wave generation in humans during 40Hz GENUS stimulation.
• The identified brain regions are critical for sensory processing, memory functions, and are affected by AD pathology.
• This research serves as a foundation for further exploration into the neural responses to 40Hz visual and auditory stimulation.